Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ibrahim, P. Marsden, J. Morris, J. Smith, A. Custovic, M. Nilsson, S. Fowler (Manchester, Preston, United Kingdom). NMR spectroscopy of exhaled breath condensate in the diagnosis of asthma: Validation and reproducibility. Eur Respir J 2010; 36: Suppl. 54, 1271

Member's Comments

No comment yet.

Related content which might interest you: Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma Source: Eur Respir J 2012; 39: 500-502 Year: 2012 Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Source: Eur Respir J 2008; 32: 1175-1183 Year: 2008 Methodological aspects of nuclear magnetic resonance spectroscopy of exhaled breath condensate Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006 Reproducibility of exhaled breath condensate pH in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004 Reproducibility of cysteinyl-leukotriene measurements in exhaled breath condensate in children Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Source: Eur Respir J 2011; 37: 468 Year: 2011 Exhaled breath condensate: metabolomics Source: Eur Respir Monogr 2010; 49: 231-236 Year: 2010 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Reproducibility of exhaled breath condensate markers Source: Eur Respir J 2008; 32: Year: 2008 Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Technical problems with measurements of biomarkers - exhaled breath condensate Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Reproducibility of exhaled breath condensate pH measurements with a hand-held device in wheezing children Source: Eur Respir J 2006; 28: Suppl. 50, 789s Year: 2006 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Detection of radicals by electron spin resonance (ESR) spectroscopy in exhaled breath condensate (EBC) Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004